Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1992 Nov;35(6):417–420. doi: 10.1007/BF01789021

Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer

Elaine J Derbyshire 1, Rolf A Stahel 2, Edward J Wawrzynczak 1,
PMCID: PMC11038155  PMID: 1327529

Abstract

The cytotoxic properties of a ricin A chain immunotoxin made with the mouse monoclonal antibody SWA20, recognising a family of sialoglycoprotein antigens selectively expressed by human small-cell lung cancer (SCLC), were examined using a panel of tumour cell lines in tissue culture. SWA20—ricin-A-chain was selectively toxic to the SW2, NCI-H69 and GLC-8 SCLC cell lines, inhibiting the incorporation of [3H]leucine by 50% at a concentration of 0.2–2 nM, but had no selective activity against the NCI-H23 and NCI-H125 lung adenocarcinoma or the control CEM T-lymphoblastoid cell lines. The SWA20 immunotoxin intoxicated the SW2 cell line rapidly, inhibiting [3H]leucine incorporation by 50% within 2 h compared with 0.5 h for ricin. Analysis of the effects of SWA20—ricin-A-chain on the growth of SW2 cells using a limiting-dilution clonogenic assay revealed that the immunotoxin could eliminate 95% of clonogenic malignant cells. Although SWA20—ricin-A-chain was found to be rapidly active against the majority of tumour cells, its action was limited by the presence of insensitive cells expressing low levels of the target antigen.

Key words: Ricin A chain, Immunotoxin, Small-cell lung cancer, Cluster-5A antigen

References

  • 1.Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985;45:2913–2923. [PubMed] [Google Scholar]
  • 2.Cumber AJ, Forrester JA, Foxwell BMJ, Ross WCJ, Thorpe PE. Preparation of antibody-toxin conjugates. Methods Enzymol. 1985;112:207–225. doi: 10.1016/s0076-6879(85)12018-5. [DOI] [PubMed] [Google Scholar]
  • 3.Derbyshire EJ, Henry RV, Stahel RA, Wawrzynczak EJ (1992) Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines. Br J Cancer (in press) [DOI] [PMC free article] [PubMed]
  • 4.Johnson EA, Brown BW., Jr. The Spearman estimator for serial dilution assays. Biometrics. 1961;27:79–88. [Google Scholar]
  • 5.Maier A, Schmidt U, Waibel R, Hartung W, Stahel RA. Expression of the small cell carcinoma antigens of cluster-5 and cluster-5A in primary lung tumors. Br J Cancer. 1989;59:692–695. doi: 10.1038/bjc.1989.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Postmus PE, de Leij L, van der Veen AY, Mesander G, Buys CHCM, Elema JD. Two small cell lung cancer cell lines established from bronchoscope biopsies. Eur J Clin Oncol. 1988;24:753–763. doi: 10.1016/0277-5379(88)90311-2. [DOI] [PubMed] [Google Scholar]
  • 7.Souhami RL, Beverley PCL, Bobrow LG. Antigens of small cell lung cancer. First International Workshop. Lancet. 1987;II:325–326. doi: 10.1016/s0140-6736(87)90904-4. [DOI] [PubMed] [Google Scholar]
  • 8.Souhami RL, Beverley PCL, Bobrow LG, Ledermann JA. Antigens of lung cancer: results of the Second International Workshop on Lung Cancer antigens. JNCI. 1991;83:609–612. doi: 10.1093/jnci/83.9.609. [DOI] [PubMed] [Google Scholar]
  • 9.Waibel R, O'Hara CJ, Stahel RA. Characterization of an epithelial and a tumor-associated human small cell lung carcinoma glycoprotein antigen. Cancer Res. 1987;47:3766–3770. [PubMed] [Google Scholar]
  • 10.Waibel R, O'Hara CJ, Smith A, Stahel RA. Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20. Cancer Res. 1988;48:4318–4323. [PubMed] [Google Scholar]
  • 11.Waibel R, O'Hara CJ, Stahel RA. Monoclonal antibodies defining the cluster-5A small cell lung carcinoma antigen. Br J Cancer. 1991;63(Suppl 14):29–32. [PMC free article] [PubMed] [Google Scholar]
  • 12.Wawrzynczak EJ. Systemic immunotoxin therapy of cancer: advances and prospects. Br J Cancer. 1991;64:624–630. doi: 10.1038/bjc.1991.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen. Br J Cancer. 1990;62:410–414. doi: 10.1038/bjc.1990.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer. Br J Cancer. 1991;63(Suppl 14):71–73. [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES